Ask a question about this product
Competitor Analysis: NGF-TrkA Pathway Agonists & Antagonists 2016
This Competitive Intelligence report about NGF-TrkA Pathway Agonists & Antagonist provides a competitor evaluation in the field of recombinant antibodies, proteins and small molecules acting as antagonists or agonists of NGF or its high affinity receptor TrkA as of October 2016. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of currently active projects in research and development of antagonists or agonists of the nerve growth factor (NGF) – TrkA pathway. In addition, the report lists company- and academia-specific R&D pipelines of Immunotoxins. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Product Category,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
Competitor Analysis NGF-TrkA Pathway Agonists & Antagonists 2016
Table of Contents
1) NGF-TrkA Pathway Agonists & Antagonists
- NGF Inhibitors
- TrkA Antagonists for pain
- TrkA Antagonists in oncology
- NGF Agonists
2) Corporate NGF-TrkA Pathway R&D Pipeline